bn 50739 has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzpatrick, JH; Gilboe, DD; Kintner, DB | 1 |
| Baker, KE; Curtis, MJ | 1 |
| Feuerstein, G; Frerichs, KU; Hallenbeck, JM; Lindsberg, PJ; Yue, TL | 1 |
3 other study(ies) available for bn 50739 and Disease Models, Animal
| Article | Year |
|---|---|
Hyperglycemic damage to mitochondrial membranes during cerebral ischemia: amelioration by platelet-activating factor antagonist BN 50739.
Topics: Animals; Azepines; Blood Pressure; Brain; Disease Models, Animal; Electroencephalography; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Femoral Artery; Hyperglycemia; Intracellular Membranes; Ischemic Attack, Transient; Lipid Peroxidation; Male; Membrane Lipids; Mitochondria; Oxygen Consumption; Phospholipids; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reference Values; Reperfusion; Thiobarbituric Acid Reactive Substances; Time Factors; Triazoles | 1997 |
Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism.
Topics: Animals; Anti-Arrhythmia Agents; Azepines; Disease Models, Animal; Male; Myocardial Ischemia; Perfusion; Platelet Activating Factor; Protective Agents; Rats; Rats, Wistar; Triazoles; Vasodilation; Ventricular Fibrillation | 1999 |
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits.
Topics: Animals; Azepines; Cerebrovascular Disorders; Disease Models, Animal; Platelet Activating Factor; Rabbits; Reference Values; Regional Blood Flow; Spinal Cord; Spinal Cord Injuries; Triazoles | 1990 |